{"id":"W4282031579","doi":"10.1038/s41391-022-00548-z","title":"The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; International Prostate Symptom Score; Lower urinary tract symptoms; Quality of life (healthcare); Urology; Prostate; Implant; Adverse effect; Hyperplasia; Sexual function; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009954268,0.000785517,0.001044321,0.000242101,0.0001861764,0.000652337,0.0005715148,0.001163002,0.004201503],"category_scores_gemma":[0.0006421314,0.0002211735,0.0009738053,0.0001677791,0.0004520805,0.0005852319,0.0002434521,0.001830445,0.0005689345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002983843,"about_ca_system_score_gemma":0.0005448966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002827912,"about_ca_topic_score_gemma":0.000774233,"domain_scores_codex":[0.9997634,0.0001006425,0.00001324612,0.00005054276,0.0000292082,0.00004298936],"domain_scores_gemma":[0.9996321,0.0001181187,0.0001075421,0.00003528205,0.00001784692,0.00008910518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8600957,0.01507098,0.002246866,0.001805851,0.0007056117,0.0001579305,0.000142186,0.0006113526,0.01519022,0.0003999966,0.001811182,0.1017621],"study_design_scores_gemma":[0.6491012,0.3319258,0.008780918,0.0001383114,0.0006600704,0.0003558567,0.00004445386,0.0008861459,0.004632051,0.0002366286,0.003205165,0.00003343626],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869343,0.007218654,0.0006417428,0.0004231698,0.0002604325,0.001310737,0.0005928029,0.0000686834,0.002549355],"genre_scores_gemma":[0.9821253,0.004547584,0.001590553,0.001063462,0.0005231732,0.002009995,0.001200864,0.00002181833,0.006917208],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004201503,"threshold_uncertainty_score":0.01405543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132998256613281,"score_gpt":0.3113775684921714,"score_spread":0.2900475859260385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}